Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 01 June, 2011 and appeared in  ObesityPreventionIssue 576

How Important Is Fat Distribution?

In obese individuals, the distribution of adipose tissue both on the body, and in the liver and skeletal muscle is an important predictor of insulin sensitivity....

Advertisement

Jürgen Machann, Dipl. Phys., from the Section on Experimental Radiology at University Hospital in Tübingen, Germany, stated that, "BMI alone seems to be not a good measure for obesity in terms of metabolic alterations." "There seems to be a benign form of adiposity. The lower the fat on the body, the better for the metabolic status, expressed as insulin sensitivity," he said.

The study included 144 obese volunteers, of whom 90 were female and 54 male, with an average age of 47 and 44 years, respectively. All subjects were at increased risk of developing type 2 diabetes and had body mass indices (BMIs) of between 33 and 35 kg/m2.

Adipose tissue measurements included total adipose tissue; visceral adipose tissue; subcutaneous abdominal adipose tissue; adipose tissue of the lower extremities, measured from the feet to the head of the femur; and adipose tissue of the upper extremities, ranging from the head of the humerus to tips of the fingers.

The subjects were divided into 2 groups based on those who were insulin sensitive or insulin resistant after an oral glucose tolerance test.

Despite no significant differences between the groups in terms of BMI, percentage of total adipose tissue (between 37% and 49%), or percentage of subcutaneous abdominal adipose tissue (between 14% and 20%), subjects who were insulin resistant had a higher percentage of visceral adipose tissue compared with insulin-sensitive subjects -- a difference that just missed statistical significance (5.2% vs. 5.9%, P = .07) in males but was significant in females (3.3% vs.3.9%, P = .02), said Dr. Machann.

In contrast, insulin-sensitive subjects had a higher percentage of lower-extremity adipose tissue compared with insulin-resistant subjects (14% vs.12% [P = .04] in males and 20% vs. 18% [P = .002] in females).

The picture for upper body adipose tissue was less clear, with insulin-resistant females showing significantly higher percentages than insulin-resistant females but insulin-resistant males showing slightly lower percentages than males with insulin sensitivity.

Hepatic lipids are more than doubled in both insulin-resistant males and females compared with insulin-sensitive subjects (P < .001 for both), Dr. Machann reported.

"Benign" adiposity seems to be characterized by decreased levels of hepatic lipids and increased amounts of adipose tissue in the lower extremities, the German investigator concluded.

"This reflects the well-known apple and pear shape, but we have to recognize that there are even male pears and female apples," he said.

The findings underscore the valuable role that imaging could play in daily clinical practice.

"If there's some concern based on a patient's weight or BMI you could go get a more accurate answer with imaging," commented Scott Reeder, MD, PhD, comoderator of the session, associate professor, and section chief of MRI and cardiovascular imaging at the University of Wisconsin School of Medicine and Public Health in Madison. "Previously, it would take many hours to segment all those areas and to measure the visceral vs. subcutaneous fat, but now there's more automated ways of doing this. So, for example, with just a couple of minutes of scanning and then automated segmentation you can get the answer right away, and that really brings the cost down. It's fast, it's noninvasive, and it's inexpensive."

International Society for Magnetic Resonance in Medicine (ISMRM) 2011 Annual Meeting: Abstract 739. Presented May 13, 2011

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 June, 2011 and appeared in  ObesityPreventionIssue 576

Past five issues: Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 | Diabetes Clinical Mastery Series Issue 83 | Issue 624 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Generics are usually just as safe and effective as the corresponding name-brand product.

Navigate Diabetes In Control
Search Articles On Diabetes In Control